Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Buntanetap

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,600,000Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Annovis Publishes Historical Review in The Scientist
    Annovis Publishes Historical Review in The Scientist

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3265424/0/en/Annovis-Publishes-Historical-Review-of-Buntanetap-in-The-Scientist.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    Annovis Reports Fiscal Year 2025 Financial Results
    Annovis Reports Fiscal Year 2025 Financial Results

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256164/0/en/Annovis-Provides-Corporate-Updates-and-Reports-Fiscal-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    Annovis Announces Two Presentations at the AD/PD 2026 Conference
    Annovis Announces Two Presentations at the AD/PD 2026 Conference

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248286/0/en/Annovis-Announces-Two-Presentations-at-the-AD-PD-2026-International-Conference.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Annovis Advances Buntanetap Phase 3 Trial In Alzheimer Disease
    Annovis Advances Buntanetap Phase 3 Trial In Alzheimer Disease

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3237130/0/en/Annovis-Secures-DSMB-Approval-to-Advance-Pivotal-Phase-3-Trial-of-Buntanetap-in-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share
    Annovis Initiates Open-Label Extension Study In Parkinson Patient
    Annovis Initiates Open-Label Extension Study In Parkinson Patient

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3208204/0/en/Annovis-Announces-Open-Label-Extension-Study-for-Parkinson-s-Disease-Patients.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    Annovis To Present At 2025 Parkinson Study Group Meeting
    Annovis To Present At 2025 Parkinson Study Group Meeting

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3198821/0/en/Annovis-To-Present-at-the-2025-Annual-Meeting-of-the-Parkinson-Study-Group.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.